Holen Sie sich die Stockscreener-App
78.79
0.24%
0.19
Handel nachbörslich:
78.79
Schlusskurs vom Vortag:
$78.60
Offen:
$78.42
24-Stunden-Volumen:
1.01M
Relative Volume:
0.73
Marktkapitalisierung:
$18.30B
Einnahmen:
$4.03B
Nettoeinkommen (Verlust:
$789.50M
KGV:
40.82
EPS:
1.93
Netto-Cashflow:
$1.15B
1W Leistung:
-0.76%
1M Leistung:
-3.41%
6M Leistung:
+5.03%
1J Leistung:
+9.63%
1-Tages-Spanne:
$78.09
$79.23
1-Wochen-Bereich:
$77.42
$80.21
52-Wochen-Spanne:
$67.59
$84.67
Hologic Inc Stock (HOLX) Company Profile
Firmenname
Hologic Inc
Sektor
Telefon
(508) 263-2900
Adresse
250 CAMPUS DRIVE, MARLBOROUGH, MA
Vergleichen Sie HOLX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
| HOLX | 78.79 | 18.30B | 4.03B | 789.50M | 1.15B | 1.93 |
| ISRG | 531.64 | 190.09B | 7.87B | 2.24B | 586.00M | 4.25 |
| BDX | 224.10 | 65.14B | 20.18B | 1.73B | 3.07B | 5.51 |
| ALC | 85.81 | 42.44B | 9.76B | 1.16B | 665.00M | 0.72 |
| RMD | 239.42 | 34.99B | 4.81B | 1.11B | 1.35B | 6.16 |
| WST | 307.21 | 22.29B | 2.88B | 499.60M | 321.60M | 7.41 |
Hologic Inc Stock (HOLX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-10-01 | Herabstufung | Citigroup | Buy → Neutral |
| 2024-06-27 | Eingeleitet | Stephens | Overweight |
| 2024-04-03 | Hochstufung | Citigroup | Neutral → Buy |
| 2023-07-14 | Hochstufung | Needham | Hold → Buy |
| 2022-12-07 | Eingeleitet | RBC Capital Mkts | Sector Perform |
| 2022-10-13 | Eingeleitet | Mizuho | Buy |
| 2022-07-20 | Herabstufung | BofA Securities | Buy → Neutral |
| 2022-07-20 | Eingeleitet | UBS | Neutral |
| 2022-07-18 | Herabstufung | BTIG Research | Buy → Neutral |
| 2022-04-25 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2022-04-04 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2021-12-15 | Herabstufung | Citigroup | Buy → Neutral |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2021-10-14 | Eingeleitet | Redburn | Neutral |
| 2021-07-06 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2020-11-20 | Herabstufung | Needham | Buy → Hold |
| 2020-11-05 | Bestätigt | Needham | Buy |
| 2020-06-30 | Hochstufung | Cowen | Market Perform → Outperform |
| 2020-06-03 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2020-04-30 | Bestätigt | Needham | Buy |
| 2020-04-30 | Hochstufung | SVB Leerink | Mkt Perform → Outperform |
| 2020-04-07 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2020-03-27 | Hochstufung | Morgan Stanley | Underweight → Equal-Weight |
| 2020-01-13 | Bestätigt | Needham | Buy |
| 2020-01-08 | Eingeleitet | Wells Fargo | Equal Weight |
| 2020-01-07 | Eingeleitet | Citigroup | Buy |
| 2020-01-02 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2019-09-26 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2019-08-01 | Bestätigt | Needham | Buy |
| 2019-05-02 | Bestätigt | Needham | Buy |
| 2019-01-31 | Bestätigt | Needham | Buy |
| 2019-01-02 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2018-10-09 | Eingeleitet | UBS | Neutral |
| 2018-09-13 | Herabstufung | BofA/Merrill | Buy → Neutral |
Alle ansehen
Hologic Inc Aktie (HOLX) Neueste Nachrichten
Hologic Inc. stock rises Monday, still underperforms market - MarketWatch
Is Weakness In Hologic, Inc. (NASDAQ:HOLX) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects? - Simply Wall St
North America Diagnostic Imaging Market 2024-2031 Revenues - openPR
Hologic, Inc. (NASDAQ:HOLX) Shares Sold by ING Groep NV - MarketBeat
Hologic Inc. stock underperforms Friday when compared to competitors despite daily gains - MarketWatch
Cornercap Investment Counsel Inc. Has $1.40 Million Holdings in Hologic, Inc. (NASDAQ:HOLX) - MarketBeat
Should You Retain Hologic Stock in Your Portfolio Now? - Yahoo Finance
Hologic Inc.: Expanding Diagnostic Assay Portfolio For A Competitive Edge!Major Drivers - Smartkarma
T. Rowe Price Investment Management, Inc. Reduces Stake in Hologic Inc. - GuruFocus.com
Hologic Inc. stock underperforms Thursday when compared to competitors - MarketWatch
William Blair Has Optimistic Outlook of Hologic Q2 Earnings - MarketBeat
Hologic to Webcast Presentations at Upcoming Investor Conferences - Marketscreener.com
Hologic to Present at Three Major Healthcare Investment Conferences in Q4 | HOLX Stock News - StockTitan
12,585 Shares in Hologic, Inc. (NASDAQ:HOLX) Acquired by Entropy Technologies LP - MarketBeat
Entropy Technologies LP Buys Shares of 12,585 Hologic, Inc. (NASDAQ:HOLX) - MarketBeat
Hologic, Inc. (NASDAQ:HOLX) Holdings Raised by Principal Financial Group Inc. - MarketBeat
Hologic (NASDAQ:HOLX) Upgraded to Buy at StockNews.com - MarketBeat
Hologic Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
William Blair Has Pessimistic Outlook of Hologic Q1 Earnings - MarketBeat
Hologic Inc. stock outperforms competitors on strong trading day - MarketWatch
Victory Capital Management Inc. Reduces Stock Holdings in Hologic, Inc. (NASDAQ:HOLX) - MarketBeat
Biopsy Devices Market: Size, Share, and Growth Trends with - openPR
Van ECK Associates Corp Invests $725,000 in Hologic, Inc. (NASDAQ:HOLX) - MarketBeat
Digital Radiography Systems Market Forecasted for Major - openPR
Hologic Announces Partnership with NFL Rookie Kelee Ringo and Family - Quantisnow
Versor Investments LP Invests $1.68 Million in Hologic, Inc. (NASDAQ:HOLX) - MarketBeat
HIV Diagnostics Test Market Detailed In New Research Report 2024 - openPR
Hologic Beats on EPS But GAAP Results Lag - AOL
Hologic Inc. stock outperforms competitors despite losses on the day - MarketWatch
Hologic Updates Executive Compensation Agreements for 2025 - TipRanks
Implied Volatility Surging for Hologic (HOLX) Stock Options - Yahoo Canada Finance
Hologic, Inc. (HOLX) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance
Hologic Post Q4 Earnings Miss: Time to Buy, Hold or Sell the Stock? - Yahoo Finance
Hologic, Inc. (NASDAQ:HOLX) Shares Sold by Olstein Capital Management L.P. - MarketBeat
Leerink Partnrs Has Positive Outlook for Hologic Q2 Earnings - MarketBeat
Leeward Investments LLC MA Decreases Stock Holdings in Hologic, Inc. (NASDAQ:HOLX) - MarketBeat
National Pension Service Sells 15,791 Shares of Hologic, Inc. (NASDAQ:HOLX) - MarketBeat
Robeco Institutional Asset Management B.V. Purchases 26,723 Shares of Hologic, Inc. (NASDAQ:HOLX) - MarketBeat
Hologic Inc. stock rises Wednesday, still underperforms market - MarketWatch
Leerink Partnrs Has Bearish Estimate for Hologic Q1 Earnings - MarketBeat
Hologic revenue increases 4.5% to USD 987.9M in Q3 2024 - Medical Buyer
Hologic's SWOT analysis: diagnostics leader faces growth challenges - Investing.com
Hologic (NASDAQ:HOLX) Price Target Raised to $90.00 - MarketBeat
Hologic (NASDAQ:HOLX) Shares Gap Down on Analyst Downgrade - MarketBeat
Raymond James Raises Hologic (NASDAQ:HOLX) Price Target to $95.00 - MarketBeat
Mizuho Issues Pessimistic Forecast for Hologic (NASDAQ:HOLX) Stock Price - MarketBeat
Hologic (NASDAQ:HOLX) Price Target Raised to $89.00 - MarketBeat
Needham maintains Buy on Hologic shares following F4Q24 revenue beat By Investing.com - Investing.com UK
Hologic's SWOT analysis: diagnostics leader faces growth challenges By Investing.com - Investing.com Australia
Hologic Q4 Earnings Lag, Revenues Top, Stock Down In Aftermarket - Barchart
Hologic (NASDAQ:HOLX) Announces Quarterly Earnings Results, Meets Expectations - MarketBeat
Finanzdaten der Hologic Inc-Aktie (HOLX)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.78%
2.70%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):